Report: Tweaking Dabigatran Increases its Safety at AF Ablation
More and more groups are now tweaking periprocedural anticoagulation strategies for the patients who are being given Dabigatran and who have undergone radiofrequency (RF) ablation for atrial fibrillation (AF). Now,...
Public Citizen Warns AF Patients Against Using Rivaroxaban, Dabigatran
A group known as Public Citizen is trying to warn atrial fibrillation (AF) patients against using the popular anticoagulant medications Dabigatran (Pradaxa) and Rivaroxaban (Xarelto) because of the drugs’ links...
Study: Pradaxa May Increase Risk of Infection
Information from a new study shows that the newer anticoagulant medication Pradaxa (dabigatran) may cause patients to develop viral infections that may be fatal to kids and young adults. The...
Study Finds AF Patients Have Worse Outcomes of Heart Failure
A large observational study that compared patient outcomes in atrial fibrillation (AF) patients vs. those who also suffered from heart failure (HF) has found that the AF patients have worse...
Study Looks to Shed Light on Alternative AF Treatments
With atrial fibrillation (AF) being a more common condition affecting millions of people worldwide, many researchers are looking to find alternative treatments to the current batch of prescription medications that...